AFP and hepatocellular carcinoma: Furthermore, it is generally known that des-gamma-carboxy prothrombin (DCP) is an abnormal form of the coagulation protein and is considered a complementary biomarker to alpha fetoprotein (AFP) for assessing the risk of developing HCC.